An international, phase IIb trial of NT-814 in women with post-menopausal vasomotor symptoms (PMVMS)

Trial Profile

An international, phase IIb trial of NT-814 in women with post-menopausal vasomotor symptoms (PMVMS)

Planning
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs NT 814 (Primary)
  • Indications Vasomotor symptoms
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2017 New trial record
    • 27 Sep 2017 According to a KaNDy Therapeutics media release, this will be an international trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top